Misdiagnosis of Suspected Cancer in Pancreatoduodenectomy: A Systematic Review and Prevalence Mata-Analysis [0.03%]
胰十二指肠切除术中疑似癌症误诊的系统评价和患病率荟萃分析
Luis F Leite da Siva,Luiz F Costa de Almeida,Marcos Belotto et al.
Luis F Leite da Siva et al.
Background: Differentiating between pancreatic cancer (PC) and benign pancreatic lesions is challenging, leading to misdiagnosis and unnecessary pancreatoduodenectomy (PD). This systematic review and meta-analysis aimed t...
Association of Preoperative and Postoperative Serum Albumin Levels with Colorectal Cancer Outcomes: a Retrospective Cohort Study [0.03%]
术前和术后血清白蛋白水平与结直肠癌结局的关系：回顾性队列研究
Yaxue Chen,Yanli Li,Mengmei Liu et al.
Yaxue Chen et al.
Purpose: To elucidate the correlation between perioperative serum albumin concentrations and clinical outcomes in patients with colorectal carcinoma. Meth...
Gastric Cancer with Peritoneal Metastases: Why Patient-Reported Outcomes Matter in Clinical Trials [0.03%]
胃癌伴腹膜转移：患者报告结果在临床试验中的重要性
Eoghan Burke
Eoghan Burke
Gastric cancer with peritoneal involvement is becoming increasingly common, particularly among younger patients with diffuse-type disease. This aggressive subtype carries a high symptom burden and severely impacts quality of life (QoL). Nov...
Resection Margin and Lymph Node Metastasis in Intrahepatic Cholangiocarcinoma: Does Margin Status Matter in Nodal Disease? [0.03%]
肝内胆管细胞癌的切缘和淋巴结转移：切缘状态对淋巴结疾病有影响吗？
Poowanai Sarkhampee,Weeris Ouransatien,Satsawat Chansitthichok et al.
Poowanai Sarkhampee et al.
Background: Lymph node metastasis (LNM) is a poor prognostic factor in intrahepatic cholangiocarcinoma (iCCA). However, the clinical benefit of R0 resection in patients with LNM is uncertain. This study evaluates the infl...
Exploring Recurrence Patterns of Esophageal Carcinoma Post-Curative Resection: a Comprehensive Study from a High-Volume Oncology Center in India [0.03%]
食管癌手术治愈术后复发规律的探究——印度高容量肿瘤中心综合研究
Amitabha Mandal,Rohan Kapoor,Sandeep Bhoriwal et al.
Amitabha Mandal et al.
Purpose: Carcinoma esophagus is an aggressive malignancy with high recurrence rates even after curative resection. This study aimed to evaluate recurrence patterns-both locoregional and systemic-after curative esophagecto...
The Association Between Proton Pump Inhibitor Use and Gastroenteropancreatic Neuroendocrine Tumors: A Systematic Review [0.03%]
质子泵抑制剂的使用与胃肠道和胰腺神经内分泌肿瘤关联性的系统评价
Yasamin Moeinipour,Farshad Abedi,Masoumeh Sadeghi et al.
Yasamin Moeinipour et al.
Purpose: This systematic review evaluated the site-specific association between long-term use of proton pump inhibitors (PPIs) and neuroendocrine tumors (NETs), with a primary focus on gastric and duodenal NETs. ...
Recurrent Cytokine Release Syndrome in Metastatic Gastric Cancer on Nivolumab-FOLFOX: A Case Report and Mechanistic Review [0.03%]
纳武单抗联合FOLFOX治疗胃癌脑转移引发反复发作的细胞因子释放综合征一例及机制分析
Juned Islam,Zakaria Rashid,Alex B Munster et al.
Juned Islam et al.
Introduction: Cytokine release syndrome (CRS) is a hyperinflammatory condition most commonly observed following chimeric antigen receptor (CAR)-T cell therapy in haematological malignancies. However, it remains rare and u...
Predicting Tumor Regrowth in Patients Undergoing Non-Operative Management after Total Neoadjuvant Therapy [0.03%]
新辅助治疗后接受非手术管理的肿瘤患者的复发预测
Kamil Erozkan,Emily Simon,Emily Steinhagen et al.
Kamil Erozkan et al.
Introduction: Total neoadjuvant treatment (TNT) has become the standard of care for locally advanced rectal cancer (LARC), leading to increased rates of complete clinical response and expanding the potential for organ pre...
A Higher Risk of Liver Cancer in Alcoholic Fatty Liver Disease than in Non-Alcoholic Fatty Liver Disease: an Analysis of the TriNetX Dabatase [0.03%]
酒精性脂肪肝癌变风险高于非酒精性脂肪肝：TriNetX数据库分析结果
Ling-Hui Chang,Sheng-You Su,Chun Lee et al.
Ling-Hui Chang et al.
Background: Both alcohol fatty liver disease (AFLD) and non-alcohol fatty liver disease (NAFLD) are established risk factors for liver cancer development. We conduct a comparative analysis between AFLD and NAFLD to determ...
Comparative Study
Journal of gastrointestinal cancer. 2025 Oct 31;56(1):211. DOI:10.1007/s12029-025-01340-7 2025